Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07485166 · ClinicalTrials.gov registry record
Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records Databases
A clinical trial of Advanced Non-squamous Non-small-cell Lung Cancer and Advanced Non-Small Cell Squamous Lung Cancer, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- 810
- Enrollment target
- 1
- Study location
NCT07485166: Active study of Advanced Non-squamous Non-small-cell Lung Cancer and Advanced Non-Small Cell Squamous Lung Cancer, sponsored by Brigham and Women's Hospital.
NCT07485166 is a study of Advanced Non-squamous Non-small-cell Lung Cancer and Advanced Non-Small Cell Squamous Lung Cancer that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 810 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07485166, a study of Advanced Non-squamous Non-small-cell Lung Cancer and Advanced Non-Small Cell Squamous Lung Cancer, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 810 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Primary Outcome
Hazard ratio (95% CI) for overall survival
Conditions Studied
Interventions
- DRUG Initiation of nivolumab
- DRUG Initiation of docetaxel
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Somerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 810 participants |
| Start Date | 2026-03-12 |
| Est. Completion | 2027-03-12 |
What the registry record for NCT07485166 still lists
NCT07485166 is an observational study that tracks outcomes without assigning an intervention. The registered 810 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Advanced Non-squamous Non-small-cell Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Initiation of nivolumab is the first listed.
NCT07485166 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07485166 about?
NCT07485166 is a clinical study titled "Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records Databases". Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such s...
What is the current status of trial NCT07485166?
This trial is currently active not recruiting. The enrollment target is 810 participants. The study started on 2026-03-12. Estimated completion is 2027-03-12.
What conditions does trial NCT07485166 study?
This clinical trial studies the following conditions: Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Non-Small Cell Squamous Lung Cancer.
What interventions are being tested in trial NCT07485166?
The interventions under investigation include: Initiation of nivolumab (DRUG), Initiation of docetaxel (DRUG).
Who is sponsoring clinical trial NCT07485166?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07485166 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Non-squamous Non-small-cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
RECRUITING · Phase 1
-
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05519085 · 810 participants · Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- NCT06529094 · 808 participants · NA
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI